← Back
$AKBA All transactions

Akebia Therapeutics, Inc.

A

$ Value

$0

Shares

204,000

Price

$0

Filed

Feb 3

Insider

Name

Ostrowski Erik

Title

SVP, CFO, CBO & Treasurer

CIK

0001762507

Roles

Officer

Transaction Details

Transaction Date

2026-01-30

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

707,586

Footnotes

The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. | The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Filing Info

Accession No.

0001762507-26-000001

Form Type

4

Issuer CIK

0001517022

Ostrowski Erik's History

Date Ticker Type Value
2026-02-02 AKBA $49K
2026-01-30 AKBA A $0
2026-01-30 AKBA A $0
2025-06-30 AKBA $152K

Other Insiders at AKBA (90d)

Insider Bought Sold Last
Butler John P.
CEO and President
$87K $474K 2026-03-04
Burke Steven Keith
SVP, Chief Medical Officer
$94K 2026-02-02
Vickers Philip J. 2026-04-01
Grund Nicholas
Chief Commercial Officer
$118K 2026-02-02
Ostrowski Erik
SVP, CFO, CBO & Treasurer
$49K 2026-02-02
Malabre Richard C
SVP, Chief Accounting Officer
$69K 2026-02-02
Rucci Carolyn M.
SVP, Chief Legal Officer
$97K 2026-02-02